Centre Hospitalier Régional Metz-Thionville
chr-metz-thionville.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
119
Active
18
Phase 3
1
Total enrollment
4,312,256
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Glucose 30% Intravenous Solution | — | — | — | — | — | 1 | |
| Epidural analgesia | — | — | — | — | — | 1 | |
| Bilateral rectus sheath block | — | — | — | — | — | 1 |
Next readouts
- 2027-03-28
- 2028-10-10
Top conditions
- Cataract7
- Keratoconus3
- SARS CoV 2 Infection2
- Sepsis2
- Phacoemulsification2
- Osteoporosis2
- Covid192
- Cardiac Arrest2
Frequently asked questions about Centre Hospitalier Régional Metz-Thionville
- How many clinical trials does Centre Hospitalier Régional Metz-Thionville have on ClinicalTrials.gov?
- Centre Hospitalier Régional Metz-Thionville is listed as the lead sponsor on 119 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Régional Metz-Thionville's trials are in Phase 3?
- 1 of Centre Hospitalier Régional Metz-Thionville's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Centre Hospitalier Régional Metz-Thionville focus on?
- Centre Hospitalier Régional Metz-Thionville's most-studied conditions on ClinicalTrials.gov are Cataract, Keratoconus, SARS CoV 2 Infection, Sepsis, Phacoemulsification.
- When are Centre Hospitalier Régional Metz-Thionville's next clinical trial readouts?
- Centre Hospitalier Régional Metz-Thionville has 2 upcoming primary-completion readouts tracked here; the soonest is “Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults”, expected around 2027-03-28.